Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
31,286,654
-
Shares change
-
-564,762
-
Total reported value, excl. options
-
$84,158,061
-
Value change
-
-$1,622,981
-
Put/Call ratio
-
300%
-
Number of buys
-
43
-
Number of sells
-
44
-
Price
-
$2.69
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q3 2024
As of 30 Sep 2024 HARVARD BIOSCIENCE INC - Common Stock (HBIO) had 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,286,654 shares of stock of the company.
Largest 10 holders included BlackRock, Inc., PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., Harvey Partners, LLC, AMH Equity Ltd, VANGUARD GROUP INC, Granahan Investment Management, LLC, DIMENSIONAL FUND ADVISORS LP, 272 Capital LP, ROYCE & ASSOCIATES LP, and BOOTHBAY FUND MANAGEMENT, LLC.
This table shows 93 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.